Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition. | Sci Adv | 2023 | 37390206 | PubTator, text mining | PubMed |
| Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion. | Cell Stem Cell | 2023 | 37385251 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma. | Front Immunol | 2023 | 37383234 | PubTator, text mining | PubMed |
| KYNU-related transcriptome profile and clinical outcome from 2994 breast tumors. | Heliyon | 2023 | 37383199 | PubTator, text mining | PubMed |
| Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma. | Pharmaceuticals (Basel) | 2023 | 37375818 | PubTator, text mining | PubMed |
| Characterization of the Clinical Significance and Immunological Landscapes of a Novel TMEMs Signature in Hepatocellular Carcinoma and the Contribution of TMEM201 to Hepatocarcinogenesis. | Int J Mol Sci | 2023 | 37373430 | PubTator, text mining | PubMed |
| Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from Colorectal Cancer. | Genes (Basel) | 2023 | 37372349 | PubTator, text mining | PubMed |
| Identification of m7G-Related miRNA Signatures Associated with Prognosis, Oxidative Stress, and Immune Landscape in Lung Adenocarcinoma. | Biomedicines | 2023 | 37371664 | PubTator, text mining | PubMed |
| Spontaneous EBV-Reactivation during B Cell Differentiation as a Model for Polymorphic EBV-Driven Lymphoproliferation. | Cancers (Basel) | 2023 | 37370694 | PubTator, text mining | PubMed |
| Quantification of hematopoietic stem and progenitor cells by targeted DNA methylation analysis. | Clin Epigenetics | 2023 | 37370186 | PubTator, text mining | PubMed |
| Identification of TIMP1 as an inflammatory biomarker associated with temporal lobe epilepsy based on integrated bioinformatics and experimental analyses. | J Neuroinflammation | 2023 | 37365625 | PubTator, text mining | PubMed |
| Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1-3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment. | Front Oncol | 2023 | 37361567 | PubTator, text mining | PubMed |
| ICD-related risk model predicts the prognosis and immunotherapy response of patients with liver cancer. | Front Pharmacol | 2023 | 37361216 | PubTator, text mining | PubMed |
| Self-delivery of TIGIT-blocking scFv enhances CAR-T immunotherapy in solid tumors. | Front Immunol | 2023 | 37359558 | PubTator, text mining | PubMed |
| Sulfated Polysaccharide Regulates the Homing of HSPCs in a BMP-2-Triggered In Vivo Osteo-Organoid. | Adv Sci (Weinh) | 2023 | 37357138 | PubTator, text mining | PubMed |
| An Atlas of the Knee Joint Proteins and Their Role in Osteoarthritis Defined by Literature Mining. | Mol Cell Proteomics | 2023 | 37356495 | PubTator, text mining | PubMed |
| A predictive molecular signature consisting of lncRNAs associated with cellular senescence for the prognosis of lung adenocarcinoma. | PLoS One | 2023 | 37352167 | PubTator, text mining | PubMed |
| Construction of the novel immune risk scoring system related to CD8+ T cells in uterine corpus endometrial carcinoma. | Cancer Cell Int | 2023 | 37349706 | PubTator, text mining | PubMed |
| PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation. | BMC Cancer | 2023 | 37349676 | PubTator, text mining | PubMed |
| Genotoxic aldehyde stress prematurely ages hematopoietic stem cells in a p53-driven manner. | Mol Cell | 2023 | 37348497 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=19